🇺🇸 FDA
Patent

US 11278494

Manufacturing of bupivacaine multivesicular liposomes

granted A61KA61K31/445A61K47/12

Quick answer

US patent 11278494 (Manufacturing of bupivacaine multivesicular liposomes) held by Pacira Pharmaceuticals, Inc. expires Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Pacira Pharmaceuticals, Inc.
Grant date
Tue Mar 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
60
CPC classes
A61K, A61K31/445, A61K47/12, A61K47/14, A61K47/183